120 related articles for article (PubMed ID: 2272655)
21. [Changes in purine metabolism in the macrophages of mice exposed to a new synthetic analog of muramyl dipeptide].
Umanskiĭ VIu; Tarakhovskiĭ AM; Andronova TM
Biull Eksp Biol Med; 1985 Jun; 99(6):685-7. PubMed ID: 2990603
[TBL] [Abstract][Full Text] [Related]
22. The immunomodulators levamisole, muramyl dipeptide and adamantylamide dipeptide antagonize the antianxiety effect of diazepam.
Sulcová A; Gulda O
Act Nerv Super (Praha); 1989 Jun; 31(2):111-3. PubMed ID: 2572130
[No Abstract] [Full Text] [Related]
23. Biological response modifiers.
Clark JW
Cancer Chemother Biol Response Modif; 1991; 12():193-212. PubMed ID: 1931443
[No Abstract] [Full Text] [Related]
24. Regression of line-10 hepatocarcinoma with synthetic quinonyl muramyl dipeptide in strain-2 guinea pigs.
Tanio Y; Souma H; Tokushima Y; Yamamura Y; Azuma I
Gan; 1983 Apr; 74(2):192-5. PubMed ID: 6862142
[TBL] [Abstract][Full Text] [Related]
25. Muramyl dipeptide enhances survival from experimental peritonitis.
Brown GL; Foshee H; Pietsch J; Polk HC
Arch Surg; 1986 Jan; 121(1):47-9. PubMed ID: 3942499
[TBL] [Abstract][Full Text] [Related]
26. Prophylaxis and treatment of experimental lung metastases in mice after treatment with liposome-encapsulated 6-O-stearoyl-N-acetylmuramyl-L-alpha-aminobutyryl-D-isoglutamine.
Lopez-Berestein G; Milas L; Hunter N; Mehta K; Hersh EM; Kurahara CG; Vandupas M; Eppstein DA
Clin Exp Metastasis; 1984; 2(2):127-37. PubMed ID: 6543694
[TBL] [Abstract][Full Text] [Related]
27. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats.
Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S
Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128
[TBL] [Abstract][Full Text] [Related]
28. Induction of a CD8+ cytotoxic T lymphocyte response to soluble antigen given together with a novel muramyl dipeptide adjuvant, N-acetyl-D-glucosaminyl-(beta 1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine (GMDP).
Hornung RL; Longo DL; Gowda VL; Kwak LW
Ther Immunol; 1995 Feb; 2(1):7-14. PubMed ID: 7553072
[TBL] [Abstract][Full Text] [Related]
29. [Muroctasin, a muramyl dipeptide derivative].
Sosnowska D; Dzierzbicka K; Myśliwski A; Kołodziejczyk AM
Postepy Hig Med Dosw; 1992; 46(5):521-30. PubMed ID: 1298958
[TBL] [Abstract][Full Text] [Related]
30. Immunological monitoring and clinical trials of biological response modifiers.
Baseler MW; Kopp WC; Urba WJ
Cancer Chemother Biol Response Modif; 1993; 14():249-83. PubMed ID: 7508729
[No Abstract] [Full Text] [Related]
31. Muroctasin. A new muramyl dipeptide derivative, MDP-Lys(L18).
Arzneimittelforschung; 1988 Jul; 38(7A):951-1074. PubMed ID: 3190801
[No Abstract] [Full Text] [Related]
32. Muroctasin, a muramyl dipeptide derivative. An introductory overview.
Tsubura E; Azuma I; Une T
Arzneimittelforschung; 1988 Jul; 38(7A):951-2. PubMed ID: 3056425
[No Abstract] [Full Text] [Related]
33. Opposite effects of the synthetic immunomodulator, muramyl dipeptide, on rejection of mouse skin allografts.
Zídek Z; Capková J; Boubelík M; Masek K
Eur J Immunol; 1983 Oct; 13(10):859-61. PubMed ID: 6357810
[TBL] [Abstract][Full Text] [Related]
34. [Antimetastatic effect of a liposome-enclosed analog of muramyl dipeptide].
Umanskiĭ VIu; Stefanov AV; Bondar' OP; Balitskiĭ KP; Pinchuk VG
Vopr Onkol; 1988; 34(4):433-8. PubMed ID: 2837005
[TBL] [Abstract][Full Text] [Related]
35. Immunomodulatory properties of new conjugates of muramyl dipeptide and nor-muramyl dipeptide with retro-tuftsin (Arg-Pro-Lys-Thr-OMe).
Wardowska A; Dzierzbicka K; Trzonkowski P; Myśliwski A
Int Immunopharmacol; 2006 Oct; 6(10):1560-8. PubMed ID: 16919828
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and immunostimulating properties of lipophilic ester and ether muramyl peptide derivatives.
Merhi G; Coleman AW; Devissaguet JP; Barratt GM
J Med Chem; 1996 Oct; 39(22):4483-8. PubMed ID: 8893843
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin.
Ogawa T; Kotani S; Shimauchi H
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):117-25. PubMed ID: 3713372
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of experimental liver tumor growth in mice by liposomes containing a lipophilic muramyl dipeptide derivative.
Phillips NC; Tsao MS
Cancer Res; 1989 Feb; 49(4):936-9. PubMed ID: 2912563
[TBL] [Abstract][Full Text] [Related]
39. Activation of immune responses by muroctasin.
Akasaki M
Arzneimittelforschung; 1988 Jul; 38(7A):976-7. PubMed ID: 3056427
[TBL] [Abstract][Full Text] [Related]
40. Novel quinonyl derivatives of muramyl dipeptide possessing potent antitumor activity.
Kobayashi S; Fukuda T; Imada I; Fujino M; Azuma I; Yamamura Y
Chem Pharm Bull (Tokyo); 1979 Dec; 27(12):3193-6. PubMed ID: 540343
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
